DOI: 10.11607/jomi.4060, PubMed ID (PMID): 26252049Pages 953-958, Language: EnglishZimmermann, Matthias / Caballé-Serrano, Jordi / Bosshardt, Dieter D. / Ankersmit, Hendrik J. / Buser, Daniel / Gruber, ReinhardPurpose: Autologous bone is used for augmentation in the course of oral implant placement. Bone grafts release paracrine signals that can modulate mesenchymal cell differentiation in vitro. The detailed genetic response of the bone-derived fibroblasts to these paracrine signals has remained elusive. Paracrine signals accumulate in bone-conditioned medium (BCM) prepared from porcine cortical bone chips.
Materials and Methods: In this study, bone-derived fibroblasts were exposed to BCM followed by a whole genome expression profiling and downstream quantitative reverse transciptase polymerase chain reaction of the most strongly regulated genes.
Results: The data show that ADM, IL11, IL33, NOX4, PRG4, and PTX3 were differentially expressed in response to BCM in bone-derived fibroblasts. The transforming growth factor beta (TGF-β) receptor 1 antagonist SB431542 blocked the effect of BCM on the expression of the gene panel, except for IL33.
Conclusion: These in vitro results extend existing evidence that cortical bone chips release paracrine signals that provoke a robust genetic response in mesenchymal cells that is not exclusively mediated via the TGF-β receptor. The present data provide further insights into the process of graft consolidation.
Keywords: ADM, bone-conditioned medium, bone supernatant, IL11, IL33, NOX4, PRG4, PTX3, SB431542
